Colgate-Palmolive sells branded oral, personal and home care products and Hill’s pet nutrition through retail, professional and online channels worldwide.
Loading the company summary…
A snapshot of what COLGATE PALMOLIVE CO owns and owes at a point in time.
Read the company’s balance sheet in the original annual reports below.
Browse original filingsSee the original statement for its reporting period, currency, and unit.
3 reports in this collection
| Report period | Filed with SEC | Form | Source |
|---|---|---|---|
| Dec 31, 20230000021665-24-000003 | Feb 15, 2024 | 10-K | Open 10-Ksec.gov |
| Dec 31, 20240000021665-25-000008 | Feb 13, 2025 | 10-K | Open 10-Ksec.gov |
| Dec 31, 20250000021665-26-000006 | Feb 23, 2026 | 10-K | Open 10-Ksec.gov |
Dates describe the filing metadata. Figures and reporting periods should be checked against the original statement. SEC links open in a new tab.
Colgate-Palmolive’s latest supplied results show improving underlying sales and cash generation, but not a broad demand recovery. First-half 2026 sales rose 6.6% to $10.686 billion, with currency contributing more than organic growth. Restructuring pushed GAAP operating profit down while adjusted operating profit increased; higher advertising and overhead still compressed the adjusted margin. North American demand and skin health remained weak, and Hill’s growth depended on pricing despite lower organic volume. Operating cash flow improved, partly because restructuring expenses preceded payment and working-capital movements were favorable. July guidance improved for gross margin and adjusted EPS, but management still expected second-half category softness. The central trade-off is stronger productivity and reinvestment against weak demand, future restructuring payments, refinancing dependence and unresolved litigation.
Sources: 10-Q · 2026-06-30 · EX-99 · 2026-07-31
Oral care supplied 44% of first-half 2026 sales; personal care, home care and pet nutrition supplied 17%, 17% and 22%. Approximately two-thirds of sales originate outside the United States and 45% in emerging markets. This provides geographic reach but exposes earnings to currencies, trade restrictions and local competition. Walmart represented approximately 11% of 2025 sales, illustrating the importance of large retailers alongside professional and online channels.
First-quarter 2026 reporting combined Europe, most of Africa/Eurasia and skin health into EMEA, while Russia and Belarus moved to Asia Pacific. Current interim comparisons are recast; consolidated results are unchanged. They should not be connected directly to old annual regional figures. Segment profit also excludes central costs such as R&D and restructuring.
Sources: 10-Q · 2026-06-30 · 10-K · 2025-12-31 · 8-K · 2026-03-17
For the six months ended June 30, 2026, sales were $10.686 billion versus $10.021 billion. Organic growth—excluding currency, acquisitions and divestments—was 2.6%, comprising 0.7% organic volume and 1.9% pricing; currency contributed 3.8 percentage points to reported growth. In the second quarter, North American organic sales fell 3.0%, although its operating margin improved. Latin America and Asia Pacific grew organically, while EMEA’s growth included continued skin-health weakness. Hill’s organic growth of 2.1% reflected pricing against declining organic volume, including the planned private-label exit.
First-half GAAP operating profit fell to $1.980 billion from $2.156 billion. Excluding designated items, Base Business operating profit rose to $2.279 billion from $2.181 billion, but its margin fell to 21.3% from 21.8%. Current adjustments principally remove restructuring; prior-year adjustments remove ERISA litigation and acquisition costs. Second-quarter gross-margin improvement was largely reinvested in advertising and overhead. GAAP diluted EPS fell to $1.67 from $1.76 for the half, while adjusted EPS rose to $1.97 from $1.83, helped by fewer diluted shares. These exclusions do not eliminate the underlying costs.
Sources: 10-Q · 2026-06-30 · EX-99 · 2026-07-31
First-half operating cash flow rose to $1.742 billion from $1.484 billion despite lower GAAP income. Noncash restructuring adjustments and accounts-payable and other working-capital movements helped, while receivables and inventories absorbed cash. After $266 million of capital expenditure, company-defined free cash flow before dividends was $1.476 billion—equal, at reported precision, to dividends and treasury-share purchases combined. This measure does not deduct debt service.
The April 30 program expansion replaced the earlier cost estimate with $350–550 million of cumulative pretax charges. Management expects 80–90% to require cash and substantially all charges to be recognized by December 2028, not necessarily paid by then. First-half charges were $305 million, cash payments $64 million and the June accrual $228 million. Expected annualized pretax savings of $200–300 million depend on approval and implementation. Prime100, acquired April 30, 2025 for AU$471 million, reported as US$301 million, had its purchase accounting finalized in second-quarter 2026; no acquisition payment appeared in the current half.
Sources: 10-Q · 2026-06-30 · EX-99 · 2026-07-31 · 8-K · 2026-04-30 · EX-99 · 2026-04-30
June 30 cash was $1.370 billion, of which $1.350 billion was held by foreign subsidiaries. Debt declined to $7.857 billion from $7.988 billion at year-end, but commercial paper increased to $1.149 billion from $147 million to finance maturing bonds. The large decline in current debt therefore was not equivalent to deleveraging. Year-end unused credit lines of $3.641 billion included a $3 billion revolver expiring in November 2030; they are neither cash nor verified current unconditional availability. Management reported covenant compliance, but quantitative thresholds and headroom are not established. Operating leases and retirement obligations remain separate demands.
Sources: 10-K · 2025-12-31 · 10-Q · 2026-06-30
The May 1 release lowered expected 2026 gross-margin performance from growth to decline. On July 31, management improved that outlook to roughly flat and raised Base Business EPS growth guidance to mid-single digits. Sales growth guidance remained 2–6%, organic growth 1–4%, and GAAP EPS growth double digits. These are conditional forecasts based on then-current assumptions, not results. Category softness, tariffs, input costs, Middle East logistics disruption and difficulty repatriating Russian cash remain risks.
Pending talc cases reached 525 at June 30; the sources disagree on the December baseline. The $0–225 million reasonably possible loss range above accruals covers estimable disclosed matters, not all potential losses, and insurance recovery is qualified. Disputed IRS tax and interest of approximately $168 million and Brazilian acquisition-financing and separate foreign-exchange tax assessments of approximately $105 million and $28 million remain unresolved. Management believes it has grounds to prevail, not final favorable judgments. By contrast, the company’s $99 million ERISA settlement allocation had been paid; the pension plan funds the remainder.
Sources: EX-99 · 2026-04-30 · EX-99 · 2026-07-31 · 10-Q · 2026-06-30 · 10-K · 2025-12-31
USD 20.382 bn
FY2025 · GAAP · consolidated · Attribution: consolidated · Reported currency
| Fiscal year | Value | YoY |
|---|---|---|
| 2025 | USD 20.382 bn | 1.4% |
| 2024 | USD 20.101 bn | 3.3% |
| 2023 | USD 19.457 bn | — |
Consolidated sales net of returns, promotional consideration and sales taxes.
Sources: 10-K · 2025-12-31
USD 2.132 bn
FY2025 · GAAP · consolidated · Attribution: parent · Reported currency
| Fiscal year | Value | YoY |
|---|---|---|
| 2025 | USD 2.132 bn | -26.2% |
| 2024 | USD 2.889 bn | 25.6% |
| 2023 | USD 2.3 bn | — |
Consolidated net income after deducting income attributable to noncontrolling interests.
Sources: 10-K · 2025-12-31
USD 4.198 bn
FY2025 · GAAP · consolidated · Attribution: consolidated · Reported currency
| Fiscal year | Value | YoY |
|---|---|---|
| 2025 | USD 4.198 bn | 2.2% |
| 2024 | USD 4.107 bn | 9.7% |
| 2023 | USD 3.745 bn | — |
Consolidated cash flow from operating activities, including working-capital movements and noncash reconciliations.
Sources: 10-K · 2025-12-31
Reading times are estimates for the English text. Financial tables and charts may take additional time.
